Clinical Trial: CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06316661) titled 'CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF' on March 5.

Brief Summary: Heart failure with preserved ejection fraction (HFpEF) causes hospitalizations, premature mortality and high health care costs. This is also due to poor understanding of HFpEF pathogenesis and, thus, lack of specific therapies. Prompted by the recent demonstration that HFpEF clusters different clinical phenotypes, the investigators propose that these phenogroups are driven by distinct myocardial abnormalities. Cardiac Magnetic Resonance (CMR) can help filling this gap in knowledge: on top of providing gold standard measurements fo...